PEPTIMATRIX LIMITED
Significant control: Johnathan William Curd (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Peptimatrix Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Peptimatrix Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PEPTIMATRIX LIMITED is an active private limited company (company number 14771849) incorporated on 31 March 2023, registered in Nottingham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2026, showing net assets of £157k and cash of £102k, with 7 employees on average. Net assets fell 59% on the prior period (£381k). Across the last 3 periods on record the net-asset trend is volatile.
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Dr Johnathan William Curd
- has significant influence or control
- Dr Kamal Badiani
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 31 March 20233 yrs ago
- Next accounts due
- 31 December 2027in 432 days
- Confirmation statement due
- 14 April 2027in 171 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £157k | £102k | £66k | — | — | — | 7 |
| 31 March 2025 | £381k | £366k | £38k | — | — | — | 5 |
| 31 March 2024 | £14k | £11k | £80k | — | — | — | 4 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £156,875 at 31 March 2026
- Net assets down 25% or more on the prior period-58.8% vs prior period
- Cash at bank of £50,000 or moreCash £101,821
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 31 March 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 432 days
- Confirmation statement duein 171 days
- Accounts period endNet assets £157k · small accounts
- Accounts period endNet assets £381k · small accounts
- Accounts period endNet assets £14k · small accounts
- Incorporated
Similar companies in Nottingham
- PATHFINDER BIO LTDNottingham · inc. Dec 2022
- FORGE GENETICS LTDNottingham · inc. Jul 2023
- WELLCORE INNOVATIONS LTDMansfield · inc. Nov 2022
- THE CENTER FOR AQUACULTURE TECHNOLOGIES UK LIMITEDNottingham · inc. Sept 2023
- BLACK BRICKS BIO LTDNottingham · inc. Sept 2023
- DARGLE THERAPEUTICS LTDNottingham · inc. Jun 2022
All companies incorporated on 31 March 2023 · in Mar 2023.
Reminders for PEPTIMATRIX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.